Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.

ABSTRACT:

SUBMITTER: Skilton M 

PROVIDER: S-EPMC6353056 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature